Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results

Go back to Prestige Consumer Healthcare Inc. Reports Fiscal 2022 Third Quarter Results

Prestige Brands (PBH) Tops Q3 EPS by 11c; Offers 2022 Guidance

February 3, 2022 6:16 AM EST

Prestige Brands (NYSE: PBH) reported Q3 EPS of $0.99, $0.11 better than the analyst estimate of $0.88. Revenue for the quarter came in at $274.5 million versus the consensus estimate of $260.38 million.

GUIDANCE:

Prestige Brands sees FY2022 EPS of $4.00-$4.04, versus the consensus of $4.26.... More